| Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis. | |
| | |
MedLine Citation:
|
PMID: 19247208 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Background: The aspartate aminotransferase to alanine aminotransferase ratio (AAR) was seldom applied for fibrosis assessment in primary biliary cirrhosis (PBC) patients.Goals: To validate the AAR for evaluating hepatic fibrosis, disease severity, and prognosis in patients with PBC.Study: Ninety-two consecutive PBC patients were retrospectively evaluated to validate the AAR for assessing the severity of liver function, the degrees of hepatic fibrosis, and predicting outcomes.Results: AAR showed modest correlations to Mayo score, model for end-stage liver disease score, and Child-Pugh score (r2=0.156,P<0.001; r2=0.084, P=0.005; r2=0.142, P<0.001, respectively)in evaluating the severity of liver function. For 46 patients who underwent liver biopsy, 35 were in early stage fibrosis and the other 11 were in advanced fibrosis. AAR was significantly higher in patients with advanced fibrosis than those with early fibrosis (mean+/-standard deviation; 1.40+/-0.44 vs. 0.98+/-0.65,P=0.001). The AAR yielded the highest area under the receiver operating curve of 0.847 than Mayo score, model for end-stage liver disease score, and Child-Pugh score in predicting advanced fibrosis. During a median follow-up of 44.5 months, 24 patients expired and 68 patients were alive. Patients with an AAR of 1 or less had significantly better prognosis than their counterparts(P=0.043).Conclusions: AAR is a simple and reliable marker to assess liver function and hepatic fibrosis as well as to predict outcomes in PBC patients. |
| | |
Authors:
|
Chien-Wei Su; Che-Chang Chan; Hung-Hsu Hung; Teh-Ia Huo; Yi-Hsiang Huang; Chung-Pin Li; Han-Chieh Lin; Shyh-Haw Tsay; Piu-Ching Lee; Shou-Dong Lee; Jaw-Ching Wu |
Related Documents
:
|
17988228 - The international normalized ratio to prioritize patients for liver transplantation: pr... 9346568 - Acute liver failure: results of a 5-year clinical protocol. 3726118 - Hepatic amebic abscess: cholescintigraphic rim enhancement. 20407858 - Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant ... 20531518 - Rod densitometry in congenital stationary night blindness. 1173968 - Ophthalmopathy associated with primary hypothyroidism. |
Publication Detail:
|
Type: Journal Article; Validation Studies |
Journal Detail:
|
Title: Journal of clinical gastroenterology Volume: 43 ISSN: 1539-2031 ISO Abbreviation: J. Clin. Gastroenterol. Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2010-06-03 Completed Date: 2010-06-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7910017 Medline TA: J Clin Gastroenterol Country: United States |
Other Details:
|
Languages: eng Pagination: 876-83 Citation Subset: IM |
Affiliation:
|
Division of Gastroenterology, Department of Medicine, Taipei Veterans Genera Hospital, Taipei, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Alanine Transaminase / metabolism* Aspartate Aminotransferases / metabolism* Biological Markers / metabolism Biopsy Female Humans Liver / enzymology*, physiopathology Liver Cirrhosis / enzymology*, physiopathology Liver Cirrhosis, Biliary / enzymology*, physiopathology Liver Function Tests Male Middle Aged Predictive Value of Tests Prognosis ROC Curve Severity of Illness Index |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.6.1.2/Alanine Transaminase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 pat...
Next Document: Amygdala depotentiation ex vivo requires mitogen-activated protein kinases and protein synthesis.